Zerapy
PrivateLast Round
Grant
Feb 13, 2025
Total Funding Raised
$55,000
Company Overview
Zerapy is an AI-driven health technology company that provides a SaaS platform for physical therapy clinics to automate clinical documentation, patient engagement, and remote therapeutic monitoring.
Sector
Enterprise Software
Verticals
Workflow Automation, Low-Code/No-Code, Data Integration
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zerapy Comparables
Compare Zerapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PerciX Corp | 69% | |
| OneChart | 42% | |
| FOWND | 41% | |
Zerapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 13, 2025 | ||||
| Accelerator | Aug 1, 2024 |
Zerapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fairfax County | Grant |
| CREATE-X | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 4434% MoM, from 38 to 1.7K.
- Feb 13, 2025
$50K grant from Fairfax County
Zerapy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zerapy's valuation, stock price, and market status.